- Journalists Discuss Healthcare Costs’ Political Fallout, Concerns About Canceled ICE Facility
- Missouri hospital names interim chief administrative officer
- OSF taps foundation president
- Morgan Medical Center launches cardiology service line in Georgia
- The hospitals, health systems cutting jobs in 2026
- Nevada expands Medicaid dental benefits for adults
- 2 dead in Missouri hospital shooting
- New Mexico dentist fined $320K for violating Controlled Substances Act
- Ketamine: 5 notes for behavioral health leaders
- 60 statistics on hospital expenses in mid-2026
- Judge dismisses Stryker cyberattack lawsuit; plaintiffs could refile
- 42 hospitals closing departments or ending services
- Oklahoma surgeon completes world’s 1st knee procedures with Lantern ASC system
- The colonoscopy reimbursement cut GI ASCs didn’t see coming
- Aspen Dental to open Alabama office
- Anthropic’s biggest healthcare bets: 6 key moves
- Mental health admissions averaged $15.9K in total costs: 5 things to know
- DSOs target de novo practices: 7 updates
- 50+ dental executives on the move in the 1st half of 2026
- Gender ratio of nurse practitioners across 50 states
- Palomar Health, UC San Diego Health finalize JPA, form new system
- 6 DSOs making headlines
- 7 new psychiatric residency programs to know
- The ASC cost crisis, by specialty
- US Heart and Vascular expands network with 2 cardiology practice partnerships
- The states losing anesthesiology residents fastest
- 5 mergers, acquisitions in June
- South Carolina behavioral health agency cuts 47 filled positions
- U of Rochester Medical center taps GI surgery chief
- DEA moves to schedule synthetic kratom compound
- The newest weapon against insurer nonpayment — and its growing controversy
- CMS wants power to remove ‘problematic’ physicians, ASCs from Medicare
- Physician practice owner to pay $1.5M to resolve false claims allegations
- 5 DSOs that dominated Q2
- FDA Lets 20 ZYN Nicotine Pouches Claim Lower Risk Than Cigarettes; Critics Warn Of Danger
- Ultra-Processed Foods Linked To Brain Differences In Young Children
- Prompt Responses From Mom Might Lower A Baby's Risk Of Childhood Mental Health Problems
- Rehab Program Helps Lift Long COVID 'Brain Fog'
- Why Are You Right- Or Left-Handed? Experiments Suggest Surprisingly Simple Explanation
- Rural Americans More Likely To View Cancer As A Death Sentence, Poll Finds
- He Dreamed Of Becoming A Physician Assistant. New Loan Rules May Thwart Him.
- New Disease Threats Follow Trump Administration’s Health Program Cuts
- HealthQ Special: Caregiving in the Sandwich Generation
- A Mom Said Infant Formula Killed Her Baby. The Manufacturer Closed the File.
- Author Health expands mental health, dementia care services
- PDS Health opened 5 de novo offices in June
- Heartland Dental added 6 de novo offices in June
- California’s school behavioral health reimbursement program stalls
- CMS mulls tougher Medicare enrollment rules to combat fraud as part of 2027 home health payment rule
- Tenpoint debuts cast of lively everyday objects to zoom in on blurry vision hassles in Yuvezzi ad
- CMS goes live with GLP-1 Bridge program for Part D beneficiaries
- New Connecticut law expands Yale psychedelic-assisted therapy pilot
- The missing piece in crisis care? A model that avoided 1,580 ED days
- FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel
- Lonza expands partnership with US drugmaker, boosts capacity for ADCs
- Trump administration withholds funds from New York's Medicaid fraud unit
- Alcohol accounts for 74% of substance use inpatient stays: 4 things to know
- Sanofi unit in Ireland chided by FDA over manufacturing flubs linked to Altuviiio
- Regulatory tracker: FDA sets decision date for Sarepta's DMD drugs
- Can A Popular Muscle Supplement Help Treat Depression?
- Zelis rolls out AI solution to help payers navigate No Surprises Act dispute process
- BridgeBio attracts $1B in equity for new launches, but analyst smells M&A ‘dry powder’
- Melatonin Shows Promise As Safe, Cheap Painkiller, Review Concludes
- Heat Dome Coming: Tips To Stay Safe During Extreme Temps
- Diets That Lower Inflammation Might Cut Dementia Risk, Study Indicates
- Vitamins Might Be Key To Asthma Control In Children, Adults
- Kimball lays out $103M to bolster life sciences CDMO footprint across Europe, India
- Haleon teams up with Microsoft in 5-year AI pact to upgrade consumer health operations
- ACCESS Model: behavioral health edition
- Would Hunters Take A Lyme Disease Vaccine? We Asked
- Affordable Healthcare Emerges as a Voter Priority in Purple Nevada
- Newsom Vowed To Transform Kids’ Mental Health. Many California Schools Are Still Waiting.
- Plus Therapeutics rebrands as Cerenome as it deepens AI strategy
- Orca Bio makes a splash with FDA approval for cell therapy Tregzi. Could an IPO come next?
- Remarks at the Economic Club of New York
- Evernorth unveils new AI-powered specialty pharmacy program, Pharmacy Forward
- 26 states sue CMS over final Medicaid work requirements rule
- Startup Queue lands $12.6M to launch autonomous robotic pharmacy kiosks
- Carbon Health agrees to revise contracts with its California clinics, pay penalties
- Experity acquires Exdion Healthcare to accelerate on-demand care RCM automation
- AstraZeneca agrees to pay $34M to settle 'free nurses' kickback lawsuit from Texas
- From Caffeine To 'Healthy' Labeling, FDA Sets Year-End Agenda For US Food Supply
- A 40-Year-Old Law Requires ERs To Treat Everyone — Unless They Opt Out
- Major Study Supports Same-Day COVID-19 and Flu Vaccination
- American Hospital Association names Steve Walsh as next CEO
- Medical journal retracts Tavneos pivotal study article, complicating Amgen’s defense effort
- Hyro rolls out analytics platform to glean insights from AI agent interactions
- Women With Parkinson's More Likely To Have Brain Changes Related To Alzheimer's
- Even Mild Weather Changes Impact Mental Health
- Breastfeeding Might Lower ADHD Risk, Study Finds
- After monotherapy failure, AbbVie and Genmab tout Epkinly combo win in DLBCL
- FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program
- She Struggled To Get A Lifesaving Drug Even After Insurers Vowed To Help
- Trouble Getting Weight Loss Drugs Covered By Insurance? Here's What To Know
- Would Hunters Take a Lyme Disease Vaccine? We Asked
- These Church Members Disagree on Politics. Together They’re Wiping Out Medical Debt.
- He Dreamed of Becoming a Physician Assistant. New Loan Rules May Thwart Him.
- Unicycive turned away by FDA again over manufacturer’s plant shortfalls
- Roche tops oncology reputation rankings as AstraZeneca climbs back to 2nd place
- Rising Stars: How Novo Nordisk’s Tara Sparks Went from Super Bowl Fan to Super Bowl Marketer
- Rural residents falling behind urban and suburban communities on medical, cancer screenings
- CMI Media Group bridges gaps in pharma marketing tech with newly launched Ad Astra platform
- How payers, drugmakers can collaborate to drive more outcomes-based contracts
- BeOne’s Brukinsa hits goal in mantle cell lymphoma confirmatory trial
- HRSA opens applications for $140M in rural health grant funding
- ACA marketplace enrollment down by 3M as of February, new federal data show
- Cases Of Rare But Dangerous Powassan Tick Virus Rising In U.S.
- Nearly 3 in 10 Young Adults Don't Have a Regular Doctor, Survey Finds
- Clinic network CEO pleads guilty to embezzling millions for 'social media influenced' market trading
- AI playing a major role in consumers' healthcare decision-making, survey finds
- Zymeworks acquires struggling Theravance for $929M
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- Klick bags Oxford PharmaGenesis in 3rd takeover in 18 months
- FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster
- Fertility Preservation Often Overlooked In Women's Cancer Care, Review Finds
- Sedatives Pose Fall Hazard For Recently Hospitalized Seniors
- Fourth Of July Poses Burn Hazards — Here's How To Protect Kids
- Efforts To End School Vaccine Mandates Hit A Wall In Florida
- A Dog's Stride Could Be An Early Sign Of Dementia, Study Says
- Florida Hospitals Act Fast To Discharge Gun Victims — Especially if They’re Not Insured
- Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa
- Doctronic, Simple HealthKit partner to connect at-home screening with AI-powered clinical care
- HHS announces new oversight measures for TEFCA, touts 1B health records exchanged
- Cancer Drug Shortage Renews Calls For Federal Action
- 3 in 10 adults turn to AI or social media for health advice, citing difficulties accessing and affording care
- Next-Generation Blood Test Improves Detection Of Aggressive Prostate Cancer
- Saint Peter’s Healthcare System Expands Intelligent Hospital Room Initiative with hellocare.ai to Advance AI Assisted Patient Safety and Virtual Care
- As PBM industry shifts, LucyRx and Abarca Health merge to build scale
- One Brooklyn Health Selects hellocare.ai to Advance AI-Powered Virtual Care Across Its Hospitals
- Most Patients Want Docs To Break Cancer News Directly, Not Through Portal Messaging
- Statins Rarely Cause Severe Muscle Problems, Researchers Say
- Even In Blue States, Hospitals Continue To Drop Gender-Affirming Care For Youths
- Younger U.S. Generations Increasingly Fear Adulthood, Study Says
- Opioid Settlement Money Pays For Services To Battle Addiction In Rural Kentucky
- Air Force Outbreak Grows As Military Reinstates Flu-Shot Rule For Recruits
- GLP-1 Weight-Loss Boom Linked To Surge In Poison Control Calls
- Brain Scans Improve Targeting Of Magnetic Stimulation For Depression
- Estrogen Birth Control May Protect Women’s Brains As They Age
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
Michigan healthcare freedom community forum
The Democrats have gotten a lot of political mileage out of KFF's lie that PPACA health plan (ObamaCare) premiums will double at the end of this year. This lie - rebroadcast by idiot reporters - was the driving force behind weak kneed RINOs signing on to the bogus Congressional Discharge Petition 10. Chris Jacobs at Juniper Research brings the receipts:
The Health Care-Industrial Complex Is Lying About Obamacare Premiums Doubling — And They Know It
By Christopher Jacobs - December 22, 2025
Many reporters have taken KFF’s claim that ‘premium payments will double’ to mean that total ‘premiums will double,’ but that’s just not true.When others frequently misinterpret an organization’s claim, is the problem the messenger, the message, or both? Journalists — including some on its own staff — continue to draw incorrect conclusions from the work of KFF, formerly the Kaiser Family Foundation, about the Dec. 31 expiration of enhanced, Covid-era insurance subsidies. Yet KFF refuses to alter its message, suggesting a deeper ideological bias in its work.
No, Premiums Aren’t Doubling
To separate spin from facts and briefly summarize what I have stated in greater detail elsewhere: KFF’s claim that “premium payments will more than double” if the enhanced subsidies expire conflates total premiums with the net portion of premium enrollees pay out of pocket, even though the original, circa-2010 Obamacare subsidy regime will still pay 75-80 percent of the average enrollee’s premium. Moreover, because nearly half of enrollees currently qualify for benchmark coverage with no out-of-pocket premiums, focusing on percentages obscures the fact that most (but not all) households will face a modest out-of-pocket increase of roughly $50-100 per month.
Many reporters have taken KFF’s claim that “premium payments will double” to mean that total “premiums will double.” In one case, a writer at Axios acknowledged the error and corrected it. But no sooner had I convinced an editor at The Hill to correct a story claiming “premiums will double” — not least because KFF itself had called this wording inaccurate — than another story from the same publication also included an incorrect claim about premiums doubling. A CNN reporter cited KFF as a reason not to adjust her claim that “premiums will double,” even after I showed her evidence that KFF personnel concede this wording is inaccurate.
Continuing Use of a Misleading Slogan
Most notably, KFF’s Health News team made the same inaccurate claim that “premiums will double” in an article about health costs. When questioned about it, the publication appended a clarification to the story. But the incident raises more fundamental questions: Why does KFF keep using a phrase that its own reporters do not understand? And would KFF Health News, which purportedly “has editorial independence for story ideas and content,” take a critical look at the confusing terminology used by KFF researchers?
KFF declined to answer either question. KFF Health News Executive Editor Alex Wayne did not respond to my question about whether his team would scrutinize its parent organization, and KFF researchers ignored my request to issue a press release clarifying their statements and phraseology.
Reporters often describe KFF as “nonpartisan” because it, like other 501(c)(3) entities, cannot engage in party political activities. But that doesn’t mean the organization doesn’t hold ideological biases. President Drew Altman has admitted as much: “Topic selection can convey bias every bit as much as study or poll or story selection can.”
Word selection can convey bias too. KFF advertises a focus on “communications strategies that will earn trust,” but has used phrasing that multiple media outlets, including several so-called reporters specializing in health policy, have misinterpreted. When KFF persists in using this terminology, and its executives use phrases like “eye-popping premium increases” to describe cost effects averaging $50-100 per month, it’s reasonable to question whether KFF’s mission — which “is at its core … about inequality and economic security, racism, and the future of our diverse society” — has biased its work.
Press or Propaganda?
At stake is far more than what some might dismiss as semantic arguments about wonky policy terminology. KFF Health News advertises itself as the “largest health newsroom in the country.” When that newsroom, despite its claims of “editorial independence,” will not take a critical look at KFF research, then it becomes little more than a mouthpiece for the parent organization. And a wide swath of health care stories nationwide will reflect that organization’s ideological slant, which is perhaps the point.
Reasonable people can disagree about the effects of a $50-100 monthly cost increase on households of modest means if the enhanced subsidies expire. But KFF’s continued use of misleading terminology suggests an ideology that would conjure objections if the average financial effect on enrollees were $10 or $10,000. Neither readers nor reporters should disabuse themselves of the organization’s biases.
Chris Jacobs is founder and CEO of Juniper Research Group and author of the book "The Case Against Single Payer." He is on Twitter: @chrisjacobsHC.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















